R&G PharmaStudies Co (SZSE:301333) Other Income (Minority Interest) : ¥-1.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is R&G PharmaStudies Co Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. R&G PharmaStudies Co's Other Income (Minority Interest) for the three months ended in Mar. 2024 was ¥-0.5 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-1.0 Mil.

R&G PharmaStudies Co Other Income (Minority Interest) Historical Data

The historical data trend for R&G PharmaStudies Co's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R&G PharmaStudies Co Other Income (Minority Interest) Chart

R&G PharmaStudies Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Minority Interest)

Get a 7-Day Free Trial

-3.69

-1.46

-1.12

-0.69

-0.33

R&G PharmaStudies Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Minority Interest)	Get a 7-Day Free Trial															0.11	-0.56	-0.01	0.12	-0.52

R&G PharmaStudies Co Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1.0 Mil.

R&G PharmaStudies Co (SZSE:301333) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

R&G PharmaStudies Co (SZSE:301333) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » R&G PharmaStudies Co Ltd (SZSE:301333) » Definitions » Other Income (Minority Interest)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 518, Chuangyi West Road, East District, Economic Development Zone, Tongzhou District, Beijing, CHN, 100048

Website

R&G PharmaStudies Co Ltd is a clinical trial outsourcing service provider. It offers full-chain clinical research outsourcing services, serving global pharmaceutical and medical device companies and scientific research institutions.

R&G PharmaStudies Co (SZSE:301333) Headlines

No Headlines